Panel Discussion: Developing a More Targeted Approach to Activating Treg Cells to Enhance Efficacy of Treatment in Patients

Time: 9:30 am
day: Day Two


  • Addressing the challenge of polyclonal Tregs to outline the risk of effector T cells becoming stimulated and causing damage
  • Overcoming the challenge of polyclonal Tregs through development of engineered Treg approaches
  • How can clinical outcomes with regulatory T cell therapies be improved?